Search Results - D. Ross Camidge

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

    Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center by Ahmed Alsafar, Sama L. Kareem, Bradley R. Corr, Christopher H. Lieu, Breelyn Wilky, S. Lindsey Davis, D. Ross Camidge, Antonio Jimeno, Wells A. Messersmith, Andrew Nicklawsky, Daniel Pacheco, Evelinn A. Borrayo, Jessica D. McDermott, Jennifer R. Diamond

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors

    Early Weight Gain as a Risk Factor for Increased Maximum Weight Gain Among Patients With NSCLC on Lorlatinib and Other ALK Tyrosine Kinase Inhibitors by Alexander S. Watson, MD, DPhil, Alyse W. Staley, MS, Benjamin Yoder, PharmD, BCOP, Sean J. Iwamoto, MD, Vida Alami, BA, Erin L. Schenk, MD, PhD, Tejas Patil, MD, D. Ross Camidge, MD, PhD, John M. Taormina, MD

    Published 2025-09-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: